# AngioDynamics (ANGO) — Earnings

ANGO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ango/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2027 |
| Period end | Aug 31, 2026 |
| EPS actual | −$0.04 |
| EPS estimate | −$0.11 |
| EPS surprise | +64.44% |
| Revenue surprise | +0.50% |
| Revenue | $80.9M |
| Revenue estimate | $80.5M |
| Reported | Oct 8, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/e40d510e-95dd-96c4-b196-e47e9f7d5b06.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2027 | Oct 8, 2026 | −$0.11 | −$0.04 | 64.44% | $80.5M | $80.9M |
| Q4 2026 | Jul 14, 2026 | −$0.09 | −$0.07 | 21.96% | $80.2M | $86.6M |
| Q3 2026 | Apr 2, 2026 | −$0.11 | $0.02 | 118.18% | $76.8M | $78.4M |
| Q1 2026 | Oct 2, 2025 | −$0.12 | −$0.10 | 18.30% | $72.3M | $75.7M |
| Q4 2025 | Jul 15, 2025 | −$0.12 | −$0.03 | 74.73% | $74.3M | $80.2M |
| Q3 2025 | Apr 2, 2025 | −$0.13 | −$0.08 | 38.46% | $70.3M | $72.0M |
| Q2 2025 | Jan 8, 2025 | −$0.11 | −$0.04 | 63.64% | $70.9M | $73.0M |
| Q1 2025 | Oct 3, 2024 | −$0.15 | −$0.11 | 25.02% | $67.9M | $67.5M |
| Q4 2024 | Jul 16, 2024 | −$0.17 | −$0.06 | 64.01% | $70.9M | $71.1M |
| Q3 2024 | Apr 4, 2024 | −$0.16 | −$0.16 | -3.23% | $74.2M | $66.0M |
| Q2 2024 | Jan 5, 2024 | −$0.07 | −$0.05 | 32.16% | $81.2M | $79.1M |
| Q1 2024 | Oct 4, 2023 | −$0.13 | −$0.12 | 7.69% | $77.7M | $78.7M |
| Q4 2023 | Jul 12, 2023 | $0.02 | $0.02 | -7.41% | $90.7M | $91.1M |
| Q3 2023 | Mar 30, 2023 | −$0.01 | −$0.03 | -300.00% | $83.2M | $80.7M |
| Q2 2023 | Jan 5, 2023 | −$0.01 | $0.01 | 200.00% | $84.4M | $85.4M |
| Q1 2023 | Oct 6, 2022 | −$0.02 | −$0.06 | -166.67% | $83.4M | $81.5M |
| Q4 2022 | Jul 12, 2022 | $0.01 | $0.01 | 33.33% | $82.9M | $87.0M |
| Q3 2022 | Apr 7, 2022 | −$0.01 | $0.03 | 340.00% | $76.3M | $74.0M |
| Q2 2022 | Jan 6, 2022 | $0.00 | −$0.02 | 0.00% | $77.9M | $78.3M |
| Q1 2022 | Sep 30, 2021 | −$0.05 | −$0.02 | 55.56% | $71.3M | $77.0M |

## Frequently Asked Questions

### When did AngioDynamics (ANGO) last report earnings?

AngioDynamics last reported on Oct 8, 2026, covering fiscal Q1 2027.

### Did ANGO beat earnings estimates?

Yes. AngioDynamics reported EPS of −$0.04 for Q1 2027 against a −$0.11 estimate — a 64.44% beat.

### How much revenue did ANGO report last quarter?

AngioDynamics reported $80.9M in revenue for Q1 2027, against a consensus estimate of $80.5M.

## Similar Stocks

- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [WST](https://www.lighthorse.io/tickers/wst) — West Pharmaceutical Services, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).